Hosted on MSN27m
Oppenheimer Upgrades BioMarin Pharmaceutical (BMRN)Fintel reports that on February 24, 2025, Oppenheimer upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback